Single and multiple dose escalation study of ONO 5334 in Caucasian women with postmenopausal osteoporosis

Trial Profile

Single and multiple dose escalation study of ONO 5334 in Caucasian women with postmenopausal osteoporosis

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Mar 2014

At a glance

  • Drugs ONO 5334 (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors Ono Pharmaceutical
  • Most Recent Events

    • 29 Mar 2014 New trial record
    • 01 Mar 2014 Pooled population pharmacokinetic /pharmacodynamic analysis published in the Journal of Clinical Pharmacology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top